Beranda › Diabetes Tipe 2 › Florida › Orlando
Uji klinis Diabetes Tipe 2 di Orlando, FL
24 studi untuk Diabetes Tipe 2 mencari peserta di lokasi sekitar Orlando (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
Menerima pesertaFase 2
- Florida Institute For Clinical Research, LLC, Orlando
- K2 Medical Research - Maitland, Maitland · 6 mi jauhnya
- Omega Research Orlando, Altamonte Springs · 9 mi jauhnya
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Menerima pesertaFase 3
- Florida Institute for Clinical Research, Orlando
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
Menerima pesertaFase 3
- Conquest Research, Winter Park · 5 mi jauhnya
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Menerima pesertaFase 3
- Clinical Site Partners, LLC dba Flourish Research, Winter Park · 5 mi jauhnya
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
Menerima pesertaFase 3
- Research Site, Ocoee · 10 mi jauhnya
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Menerima pesertaFase 3
- AURORA-2 Clinical Site, Winter Park · 5 mi jauhnya
A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
Menerima pesertaFase 2
- Conquest Research LLC - Winter Park, Winter Park · 5 mi jauhnya
A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
Menerima pesertaFase 2
- West Orange Endocrinology, Ocoee · 10 mi jauhnya
Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
Menerima pesertaFase 2
- Central Florida Kidney Specialists Oakwater, Orlando
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
Menerima pesertaFase 3
- Research Site, Orlando
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Menerima pesertaFase 2
- Conquest Research, Winter Park · 5 mi jauhnya
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
Menerima pesertaFase 3
- Innovus Clinical, Kissimmee · 16 mi jauhnya
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
Menerima pesertaFase 3
- Florida Institute for Clinical Research, Orlando
- Conquest Research - Winter Park, Winter Park · 5 mi jauhnya
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
Menerima pesertaFase 3
- Research Site, Orlando
- Research Site, Ocoee · 10 mi jauhnya
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
Menerima pesertaFase 3
- Research Site, Orlando
A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies
Menerima pesertaStudi observasional
- Research Site, Ocoee · 10 mi jauhnya
Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus
Menerima pesertaFase 2
- Charter Research, Orlando
- AdventHealth Translational Research Institute, Orlando
Acute Exercise and Endogenous Glucose Production in Type 2 Diabetes: Implications for Glycemic Control and Treatment of Hepatic Steatosis
Menerima pesertaSukarelawan sehat diterima
- AdventHealth Translational Research Institute, Orlando
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
Menerima pesertaFase 3
- AdventHealth Orlando, Orlando
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin
Menerima pesertaFase 3
- Research Site, Ocoee · 10 mi jauhnya
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy
Menerima pesertaFase 2
- Flourish Research Orlando, Winter Park · 5 mi jauhnya
Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus
Menerima pesertaFase 2
- Florida Institute for Clinical Research LLC, Orlando
Study to Evaluate if Exposure to Drug is Impacted in Participants With Renal Insufficiency
Menerima pesertaFase 1Sukarelawan sehat diterima
- Orlando Clinical Research Center (OCRC), Orlando
The Role of Type 2 Diabetes on Skeletal Muscle Atrophy and Recovery Following Bed Rest in Older Adults
Menerima pesertaSukarelawan sehat diterima
- Translational Research Institute for Metabolism and Diabetes, Orlando
Uji klinis Diabetes Tipe 2 di kota lain
- San Antonio, TX37 studi
- Houston, TX31 studi
- Boston, MA20 studi
- Miami, FL19 studi
- Chicago, IL19 studi
- Dallas, TX19 studi
- Columbus, OH18 studi
- Las Vegas, NV18 studi
- Atlanta, GA17 studi
- San Diego, CA17 studi
- Los Angeles, CA16 studi
- New York City, NY16 studi
Studi lain di Orlando
- Kanker Paru Non-Sel Kecil44 studi
- Obesitas31 studi
- Kanker Metastatik29 studi
- Kelebihan Berat Badan27 studi
- Penyakit Alzheimer25 studi
- Kanker (semua jenis)24 studi
- Kanker Payudara23 studi
- Kanker Ovarium22 studi
- Kolitis Ulseratif22 studi
- Kanker Paru21 studi
- Kanker Kolorektal19 studi
- Gangguan Depresi Mayor19 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.